Health and Fitness Health and Fitness
Thu, May 19, 2011
[ 12:49 PM ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Cephalon, Inc.
[ 06:30 AM ] - Market Wire
IDC ANNOUNCES COMPLETION OF RE-PRICING OF EXERCISE PRICE FOR SHARE PURCHASE WARRANTS
[ 05:30 AM ] - Market Wire
Teva and OncoGenex to Present Data on Custirsen in Prostate Cancer at the 2011 ASCO Annual Meeting
[ 05:15 AM ] - Market Wire
Immunovaccine Provides Corporate Update
[ 05:03 AM ] - Market Wire
Thermo Fisher Scientific to Acquire Phadia, a Glo .. al Leader in Allergy and Autoimmunity Diagnostics
[ 05:00 AM ] - Market Wire
International Stem Cell Corporation Enrolls First .. New Parthenogenetic Stem Cell Lines in the United
[ 05:00 AM ] - Market Wire
Unigene Announces Manufacturing and Clinical Supp .. peutics for Phase 1 Study of Novel Kappa Receptor
[ 05:00 AM ] - Market Wire
Seattle Genetics to Present Brentuximab Vedotin a .. e American Society of Clinical Oncology Annual Me
[ 04:05 AM ] - Market Wire
RXi Pharmaceuticals Presents Updated NeuVaxa" (E75) Data At ASCO
[ 04:00 AM ] - Market Wire
Compugen Discloses Discovery Method for Drug Candidates That Interfere With Protein Conformations
[ 04:00 AM ] - Market Wire
Repligen Receives FDA Approval to Initiate Phase .. f Potential Treatment for Spinal Muscular Atrophy
[ 04:00 AM ] - Market Wire
PolyMedix PMX-30063 Defensin-Mimetic Antibiotic C .. pound Shows Promising Activity for Oral Mucositis
[ 04:00 AM ] - Market Wire
Centric Health to Acquire Blue Water Surgical, Wi .. oping Centres to Expand its National Network of S
[ 03:30 AM ] - Market Wire
Enzon Announces Discontinuation of PEG-SN38 Progr .. Carcinoma in Light of Evolving Standards of Care
[ 12:32 AM ] - Market Wire
Study Provides Insight on Medtronic CoreValve® System Implants Through Subclavian Approach
Wed, May 18, 2011
[ 06:30 PM ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against Community Health Systems, Inc.
[ 04:16 PM ] - Market Wire
Zusammenarbeit zwischen Northwest Biotherapeutics .. elltherapie und Immunologie bei klinischen Studie
[ 03:17 PM ] - Market Wire
ZIOPHARM Oncology to Present Data at 2011 ASCO An .. Treatment Demonstrating Small Molecule-Controlled
[ 03:01 PM ] - Market Wire
Phase II Study Results Evaluating Effect of Olapa .. Survival in Serous Ovarian Cancer Announced Today
[ 03:00 PM ] - Market Wire
Clinical Data Evaluating AVEO Pharmaceuticalsa? T .. be Presented at the American Society of Clinical
[ 01:00 PM ] - Market Wire
Alkermes Reports Financial Results for Fiscal 201 .. d Provides Financial Expectations for Fiscal 2012
[ 01:00 PM ] - Market Wire
Fibrocell Science, Inc. Reports First Quarter 2011 Financial Results and Provides Business Update
[ 10:15 AM ] - Market Wire
Cannabis Science Announces Planned Thailand Busin .. nership and Clinical Trials for Medical Marijuana
[ 09:15 AM ] - Market Wire
Dyax Corp. to Present at the UBS Global Specialty Pharmaceuticals Conference
[ 06:58 AM ] - Market Wire
ZIOPHARM Oncology Announces Filing of Resale Registration Statement for Previous Private Placement
[ 06:45 AM ] - Market Wire
Israelisches Gesundheitsministerium genehmigt Nur .. rste klinische Studie mit adulter Stammzelltherap
[ 06:28 AM ] - Market Wire
Northwest Biotherapeutics y Fraunhofer Institute .. gy se asocian para ensayos clnicos y casos de uso
[ 06:27 AM ] - Market Wire
Nasce una collaborazione tra Northwest Biotherape .. di terapia cellulare e immunologia per la conduz
[ 06:27 AM ] - Market Wire
Northwest Biotherapeutics en het Fraunhofer Insti .. nologie werken samen voor klinische proeven en ge
[ 06:15 AM ] - Market Wire
Baxter to Present at Goldman Sachs 32nd Annual Global Healthcare Conference

Baxter to Present at Goldman Sachs 32nd Annual Global Healthcare Conference


Published on 2011-05-18 06:26:00 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ BUSINESS WIRE ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Goldman Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, at 9:20 a.m. (PT) or 11:20 a.m. (CT).

The live webcast of Baxtera™s presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through July 8, 2011.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources